Algert Global’s Provention Bio, Inc. Common Stock PRVB Stock Holding History

Algert Global’s Portfolio PRVB Stock Details PRVB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-34,940	Closed	-$842K	–	1333
2023 Q1	$842K	Buy	+34,940	New	+$438K	0.04%	698
2022 Q1	–	Sell	-18,150	Closed	-$102K	–	1347
2021 Q4	$102K	Buy	+18,150	New	+$115K	0.01%	916

Other funds holding PRVB

UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

Algert Global's PRVB Position: Q2 2023 in Review

Algert Global sold out of Provention Bio, Inc. Common Stock (PRVB) in Q2 2023, closing a stake of 34,940 shares — an estimated $842K sold.

Algert Global first reported a position in PRVB in Q4 2021 and held it in 2 quarters. The position peaked at $842K in Q1 2023. 1 fund tracked by Wall St. Rank holds PRVB as of Q2 2023.

Algert Global reported no remaining Provention Bio, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
Algert Global sold 34,940 Provention Bio, Inc. Common Stock shares in Q2 2023, an estimated $842K.
Algert Global first reported a position in Provention Bio, Inc. Common Stock in Q4 2021 and held it in 2 quarters.
Algert Global's Provention Bio, Inc. Common Stock position peaked at $842K in Q1 2023.
1 fund tracked by Wall St. Rank held Provention Bio, Inc. Common Stock as of Q2 2023.

Based on Algert Global's 13F filing for Q2 2023, filed 14 Aug 2023.